The Rise Of Innovations in Botanical Supplements: Enhancing Health with Plant-Derived Ingredients Is Influencing The mRNA Therapeutics Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The mRNA Therapeutics Market In 2026, And How Will Its Value Evolve By 2030?
The mrna therapeutics market has experienced consistent expansion over recent years. It is projected to increase from $35.9 billion in 2025 to $37.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 3.6%. The historical rise can be ascribed to the significant achievements of mrna vaccines in treating infectious diseases, advancements in nucleic acid delivery technologies, a deeper comprehension of gene expression control, early research confirming mrna-based protein synthesis, and robust public financial backing for mrna research platforms.
The mrna therapeutics market is projected to experience consistent expansion over the upcoming years. Its valuation is anticipated to reach $42.32 billion by 2030, achieving a compound annual growth rate (CAGR) of 3.3%. This anticipated growth during the forecast period stems from factors such as an escalating need for targeted and individualized treatments, the broader application of mrna technologies in areas like oncology and rare diseases, increased biopharmaceutical funding for mrna development pipelines, a growing volume of mrna medications advancing into clinical trials, and crucial alliances formed between biotechnology companies and research institutions. Key trends expected within this period encompass the diversification of mrna therapeutics beyond vaccine development, an intensified focus on mrna-based protein replacement therapies, a burgeoning clinical development pipeline for mrna drugs not intended as vaccines, heightened financial commitments to lipid nanoparticle delivery technologies, and the rapid enhancement of comprehensive mrna manufacturing infrastructures.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp
Which Important Drivers Are Guiding The mRNA Therapeutics Market Growth?
The expanding occurrence of chronic and transmissible illnesses is projected to fuel the expansion of the mRNA therapeutics market in the future. These long-lasting and communicable diseases are conditions that endure for prolonged durations and can be transmitted from person to person, encompassing ailments like tuberculosis, HIV/AIDS, and hepatitis. The escalation of these diseases stems from factors such as enhanced global travel and deficiencies in healthcare systems, which promote higher transmission rates and impede efficient disease management. mRNA therapeutics aid in better disease control by swiftly enabling the body to generate proteins that bolster immune responses, thereby accelerating the creation of specific vaccines and treatments. For example, in March 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, showed that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the growing prevalence of long-lasting and communicable diseases is propelling the growth of the mRNA therapeutics market.
How Are Different Segments Classified In The mRNA Therapeutics Market Segment Analysis?
The mrna therapeutics market covered in this report is segmented –
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
Subsegments:
1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines
2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs
Which Trends Are Guiding The Direction Of The mRNA Therapeutics Market?
Leading companies operating within the mRNA therapeutics market are concentrating on the development of innovative solutions, such as personalized neoantigen vaccines, to improve immune responses and enhance survival outcomes for cancer patients. These personalized neoantigen vaccines are cancer therapies uniquely crafted for each patient, utilizing specific tumor mutations to stimulate the immune system to identify and eliminate cancer cells. For example, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, collaborated with Moderna Therapeutics, Inc., a US-based biotechnology company, to launch a Phase 3 randomized clinical trial (V940-001). This trial aims to evaluate mRNA-4157 (V940) in conjunction with KEYTRUDA® (pembrolizumab) for use as an adjuvant treatment in patients with resected high-risk (Stage IIB-IV) melanoma. This particular study follows the positive results obtained from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which indicated a significant benefit of the combination over KEYTRUDA alone in decreasing the risk of recurrence and distant metastasis. The Phase 3 trial seeks to confirm these findings by assessing relapse-free survival and distant metastasis-free survival as its primary and secondary endpoints, respectively.
Who Are The Companies Driving Activity In The mRNA Therapeutics Market?
Major companies operating in the mrna therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG
Get The Full mRNA Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Where Is The mRNA Therapeutics Market Most Concentrated Geographically?
North America was the largest region in the mRNA therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized mRNA Therapeutics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Browse Through More Reports Similar to the Global mRNA Therapeutics Market 2026, By The Business Research Company
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026
Rna Targeting Small Molecules Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
